633 related articles for article (PubMed ID: 17624657)
1. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
Denzinger S; Fritsche HM; Otto W; Blana A; Wieland WF; Burger M
Eur Urol; 2008 Jan; 53(1):146-52. PubMed ID: 17624657
[TBL] [Abstract][Full Text] [Related]
2. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?].
Denzinger S; Burger M; Fritsche HM; Ganzer R; Blana A; Wieland WF; Otto W
Aktuelle Urol; 2008 Jan; 39(1):58-61; discussion 62-3. PubMed ID: 18228189
[TBL] [Abstract][Full Text] [Related]
3. Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients.
Denzinger S; Otto W; Fritsche HM; Roessler W; Wieland WF; Hartmann A; Burger M
Int J Urol; 2007 Nov; 14(11):995-9; discussion 999. PubMed ID: 17956523
[TBL] [Abstract][Full Text] [Related]
4. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
5. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
[TBL] [Abstract][Full Text] [Related]
7. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
8. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
9. Survival after cystectomy for invasive bladder cancer.
de Vries RR; Nieuwenhuijzen JA; Vincent A; van Tinteren H; Horenblas S
Eur J Surg Oncol; 2010 Mar; 36(3):292-7. PubMed ID: 20097512
[TBL] [Abstract][Full Text] [Related]
10. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
[TBL] [Abstract][Full Text] [Related]
11. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
Stein JP; Penson DF
BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
[TBL] [Abstract][Full Text] [Related]
12. Treatment delay and prognosis in invasive bladder cancer.
Liedberg F; Anderson H; Månsson W
J Urol; 2005 Nov; 174(5):1777-81; discussion 1781. PubMed ID: 16217282
[TBL] [Abstract][Full Text] [Related]
13. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Granfors T; Tomic R; Ljungberg B
Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
[TBL] [Abstract][Full Text] [Related]
14. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
Holzbeierlein JM; Lopez-Corona E; Bochner BH; Herr HW; Donat SM; Russo P; Dalbagni G; Sogani PC
J Urol; 2004 Sep; 172(3):878-81. PubMed ID: 15310988
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
16. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
17. Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate.
Ferreira U; Matheus WE; Nardi Pedro R; Levi D'Ancona CA; Reis LO; Stopiglia RM; Denardi F; Rodrigues Netto N; de Cássio Zequi S; da Fonseca FP; Lopes A; Cardoso Guimarães G; de Carvalho Fernandes R; Cardenuto Perez MD
Urol Int; 2007; 79(3):200-3. PubMed ID: 17940350
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
19. Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre.
Boström PJ; Mirtti T; Kössi J; Laato M; Nurmi M
Scand J Urol Nephrol; 2009; 43(5):357-64. PubMed ID: 19921979
[TBL] [Abstract][Full Text] [Related]
20. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
